FREE e-zine for diagnostics pros. Subscribe now to this weekly email featuring G2's proprietary findings.
Upcoming G2 Events
MDx NEXT 2013
June 12-14, 2013
Westin Las Vegas Hotel Casino & Spa
Las Vegas, NV
|
- Results 1-10 of 607
- First
- Previous
- Next
- Last
5
23
2013
»Navigenics Co-Founder Takes Exception to "The Outrageous Cost of a Gene Test"
The co-founder of Navigenics and a prominent oncologist is taking exception to Myriad Genetic's pricing of its BRACAnalysis test for breast cancer. more…
5
23
2013
»Industry Executive Move: Gavin Wood
Affymetrix Inc. (Santa Clara, Calif.) has appointed Gavin Wood to the position of executive vice president and chief financial officer. more…
5
23
2013
»Mayo Clinic Teams with Cancer Genetics to Launch OncoSpire Genomics
Novel joint venture will discover and commercialize diagnostic tests that use next-generation sequencing. more…
5
23
2013
»EEOC Files First Two GINA-Related Lawsuits
So far in May the U.S. Equal Employment Opportunity Commission (EEOC) has filed its first two ever Genetic Information Nondiscrimination Act- (GINA) related lawsuits. In both cases the companies violated federal law by asking for genetic information based on family medical history. more…
5
22
2013
»Interleukin Gets Private Placement, Shakes Up Board
Waltham, Mass.-based Interleukin Genetics has shaken up its board of directors as it received a $12 million private placement from outside investors and allowed two preferred stockholders to engage in conversions to common shares. more…
5
17
2013
»In Tough Contracting Environment, Labs Must Offer ‘Complete Package’ to Increasingly Picky Payers
“With respect to lab contracting, this is the most difficult period we’ve seen, and it’s only the beginning,” said Mike Snyder, principal of Clinical Lab Business Solutions, at the outset of G2 Intelligence’s Lab Contracting Workshop. more…
5
16
2013
»CardioDx Receives CAP Certification
CardioDx, a Palo Alto, Calif.-based genomics testing firm, has received certification for its laboratory by the College of American Pathologists. more…
5
16
2013
»Quest Acquires Concentra Lab and Toxicology Services
Quest Diagnostics is continuing its expansion with the acquisition of the toxicology and clinical laboratory business of Concentra, a subsidiary of Humana. Quest also has entered into a long-term agreement to be Concentra's primary provider of workplace drug toxicology and clinical lab testing. more…
5
16
2013
»Industry Executive Move: Psychemedics Corp.
Psychemedics Corp. (Acton, Mass.) announced that Sarah Ashby has been promoted to the position of vice president and general counsel. more…
5
16
2013
»University of Maryland Launches Pharmacogenomic Testing Program For Cardiac Patients
University of Maryland Medical Center (UMMC; Baltimore) has launched a pharmacogneomic testing program as part of its personalized medicine initiative. Genetic testing is being offered to aid doctors in determining which anti-clotting medication a patient with coronary artery disease should take following a coronary catheterization procedure. more…
|
|